{"id":"https://openalex.org/W4416655751","doi":"https://doi.org/10.1126/scisignal.aea2788","title":"SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer","display_name":"SOS1 inhibition suppresses the emergence of osimertinib resistance to generate a durable response in EGFR -mutant lung cancer","alternate_titles":[],"publication_year":2025,"publication_date":"2025-11-25","ids":{"openalex":"https://openalex.org/W4416655751","doi":"https://doi.org/10.1126/scisignal.aea2788","pmid":"https://pubmed.ncbi.nlm.nih.gov/41289356","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13021283"},"language":"en","primary_location":{"id":"doi:10.1126/scisignal.aea2788","doi":"https://doi.org/10.1126/scisignal.aea2788","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scisignal.aea2788","pdf_url":null,"source":{"id":"https://openalex.org/S155937366","display_name":"Science Signaling","issn_l":"1945-0877","issn":["1945-0877","1937-9145"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Signaling","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4416655751"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13021283/pdf/nihms-2150484.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031947555","display_name":"Brianna R. Daley","orcid":"https://orcid.org/0009-0008-3018-9963","observed_orcids":["https://orcid.org/0009-0008-3018-9963"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brianna R. Daley","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","USU Physician-Scientist Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"],"raw_orcid":"https://orcid.org/0009-0008-3018-9963","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]},{"raw_affiliation_string":"USU Physician-Scientist Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078820052","display_name":"Patricia L. Theard","orcid":"https://orcid.org/0000-0001-9761-7645","observed_orcids":["https://orcid.org/0000-0001-9761-7645"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia L. Theard","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","USU Physician-Scientist Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"],"raw_orcid":"https://orcid.org/0000-0001-9761-7645","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]},{"raw_affiliation_string":"USU Physician-Scientist Program, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074448016","display_name":"Jacob M. Hughes","orcid":"https://orcid.org/0009-0007-6686-5014","observed_orcids":["https://orcid.org/0009-0007-6686-5014"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob M. Hughes","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"],"raw_orcid":"https://orcid.org/0009-0007-6686-5014","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064710374","display_name":"Bridget A. Finniff","orcid":"https://orcid.org/0009-0004-9331-9535","observed_orcids":["https://orcid.org/0009-0004-9331-9535"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bridget A. Finniff","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"],"raw_orcid":"https://orcid.org/0009-0004-9331-9535","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052456593","display_name":"Marco H. Hofmann","orcid":"https://orcid.org/0000-0001-7557-1156","observed_orcids":["https://orcid.org/0000-0001-7557-1156"]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Marco H. Hofmann","raw_affiliation_strings":["Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria"],"raw_orcid":"https://orcid.org/0000-0001-7557-1156","affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072276846","display_name":"Kaja Kostyrko","orcid":"https://orcid.org/0000-0002-2842-4089","observed_orcids":["https://orcid.org/0000-0002-2842-4089"]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Kaja Kostyrko","raw_affiliation_strings":["Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria"],"raw_orcid":"https://orcid.org/0000-0002-2842-4089","affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005667589","display_name":"Robyn L. Schenk","orcid":"https://orcid.org/0000-0002-5012-850X","observed_orcids":["https://orcid.org/0000-0002-5012-850X"]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Robyn L. Schenk","raw_affiliation_strings":["Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria"],"raw_orcid":"https://orcid.org/0000-0002-5012-850X","affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim RCV GmbH & Co KG, Vienna 1120, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007672089","display_name":"Heidi M. Vieira","orcid":"https://orcid.org/0000-0003-1555-2281","observed_orcids":["https://orcid.org/0000-0003-1555-2281"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heidi M. Vieira","raw_affiliation_strings":["Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"],"raw_orcid":"https://orcid.org/0000-0003-1555-2281","affiliations":[{"raw_affiliation_string":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082400517","display_name":"James W. Askew","orcid":"https://orcid.org/0000-0002-3110-8976","observed_orcids":["https://orcid.org/0000-0002-3110-8976"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James W. Askew","raw_affiliation_strings":["Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"],"raw_orcid":"https://orcid.org/0000-0002-3110-8976","affiliations":[{"raw_affiliation_string":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072416990","display_name":"Robert E. Lewis","orcid":"https://orcid.org/0000-0002-3616-2971","observed_orcids":["https://orcid.org/0000-0002-3616-2971","https://orcid.org/0009-0005-0177-220X"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert E. Lewis","raw_affiliation_strings":["Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051052453","display_name":"Robert L. Kortum","orcid":"https://orcid.org/0000-0002-1634-4882","observed_orcids":["https://orcid.org/0000-0002-1634-4882"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert L. Kortum","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA"],"raw_orcid":"https://orcid.org/0000-0002-1634-4882","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA","institution_ids":["https://openalex.org/I148314036"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5051052453"],"corresponding_institution_ids":["https://openalex.org/I148314036"],"apc_list":null,"apc_paid":null,"fwci":2.1212,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.85269297,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"18","issue":"914","first_page":"eaea2788","last_page":"eaea2788"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sos1-inhibition","display_name":"SOS1 inhibition","score":0.953000009059906},{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.8980000019073486},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/egfr-mutant-non-small-cell-lung-cancer","display_name":"EGFR-mutant non-small cell lung cancer","score":0.9570000171661377},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/drug-tolerant-persister-cells","display_name":"drug-tolerant persister cells","score":0.8169999718666077},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.9129999876022339},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.7799999713897705},{"id":"https://openalex.org/keywords/spheroid-culture","display_name":"spheroid culture","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9857000112533569},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7160000205039978},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5523999929428101},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.4668000042438507},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40549999475479126},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4027000069618225},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3677999973297119},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.35670000314712524},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.34769999980926514},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.34220001101493835},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3416000008583069},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.3296000063419342},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.320499986410141},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3190999925136566},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3181999921798706},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.31290000677108765},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3052999973297119},{"id":"https://openalex.org/C2780635560","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Neoplasm","level":2,"score":0.2858000099658966},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.2800999879837036},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2797999978065491},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.2745000123977661},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.27140000462532043},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.2628999948501587},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.26089999079704285},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.2547999918460846}],"mesh":[{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000814","descriptor_name":"Aniline Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020837","descriptor_name":"SOS1 Protein","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D020837","descriptor_name":"SOS1 Protein","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D020837","descriptor_name":"SOS1 Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1126/scisignal.aea2788","doi":"https://doi.org/10.1126/scisignal.aea2788","is_oa":false,"landing_page_url":"https://doi.org/10.1126/scisignal.aea2788","pdf_url":null,"source":{"id":"https://openalex.org/S155937366","display_name":"Science Signaling","issn_l":"1945-0877","issn":["1945-0877","1937-9145"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315823","host_organization_name":"American Association for the Advancement of Science","host_organization_lineage":["https://openalex.org/P4310315823"],"host_organization_lineage_names":["American Association for the Advancement of Science"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science Signaling","raw_type":"journal-article"},{"id":"pmid:41289356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41289356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Science signaling","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13021283","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13021283/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13021283/pdf/nihms-2150484.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Sci Signal","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13021283","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13021283/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13021283/pdf/nihms-2150484.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Sci Signal","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000864537","display_name":"Isoform-specific signaling as a determinant of RAS-driven oncogenesis","funder_award_id":"R01CA255232","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000918306","display_name":"Cancer Biology Training Program","funder_award_id":"T32CA009476","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G962880621","display_name":"Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers","funder_award_id":"R21CA267515","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"},{"id":"https://openalex.org/F4320312060","display_name":"Francis Crick Institute","ror":"https://ror.org/04tnbqb63"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332504","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4416655751.pdf","grobid_xml":"https://content.openalex.org/works/W4416655751.grobid-xml"},"referenced_works_count":94,"referenced_works":["https://openalex.org/W1546552389","https://openalex.org/W1979572498","https://openalex.org/W2004878973","https://openalex.org/W2050211354","https://openalex.org/W2052380264","https://openalex.org/W2081801534","https://openalex.org/W2096476771","https://openalex.org/W2099516272","https://openalex.org/W2104098330","https://openalex.org/W2106391833","https://openalex.org/W2117784514","https://openalex.org/W2121993228","https://openalex.org/W2135925682","https://openalex.org/W2138895339","https://openalex.org/W2139330399","https://openalex.org/W2140355533","https://openalex.org/W2151948621","https://openalex.org/W2162474938","https://openalex.org/W2166084034","https://openalex.org/W2166090806","https://openalex.org/W2180481128","https://openalex.org/W2184779060","https://openalex.org/W2272802268","https://openalex.org/W2275679174","https://openalex.org/W2338377057","https://openalex.org/W2474410556","https://openalex.org/W2504472048","https://openalex.org/W2547886466","https://openalex.org/W2594302711","https://openalex.org/W2605449696","https://openalex.org/W2606001457","https://openalex.org/W2750972785","https://openalex.org/W2770828094","https://openalex.org/W2772606138","https://openalex.org/W2773830451","https://openalex.org/W2792821195","https://openalex.org/W2794026637","https://openalex.org/W2795384223","https://openalex.org/W2797780609","https://openalex.org/W2809980410","https://openalex.org/W2883433181","https://openalex.org/W2886936871","https://openalex.org/W2891909134","https://openalex.org/W2901243719","https://openalex.org/W2903228835","https://openalex.org/W2906928229","https://openalex.org/W2910264472","https://openalex.org/W2917986762","https://openalex.org/W2943767349","https://openalex.org/W2964016456","https://openalex.org/W2967210753","https://openalex.org/W2974668768","https://openalex.org/W2975117225","https://openalex.org/W2976334328","https://openalex.org/W2987148655","https://openalex.org/W2990041408","https://openalex.org/W2990053855","https://openalex.org/W2999801017","https://openalex.org/W3001089266","https://openalex.org/W3017413818","https://openalex.org/W3084211591","https://openalex.org/W3085529787","https://openalex.org/W3092240262","https://openalex.org/W3099461365","https://openalex.org/W3134442664","https://openalex.org/W3154466284","https://openalex.org/W3159275491","https://openalex.org/W3174224631","https://openalex.org/W3174662367","https://openalex.org/W3181898261","https://openalex.org/W3183139760","https://openalex.org/W3187309064","https://openalex.org/W3189724491","https://openalex.org/W4205997245","https://openalex.org/W4220776360","https://openalex.org/W4283259595","https://openalex.org/W4288052521","https://openalex.org/W4309657081","https://openalex.org/W4311903085","https://openalex.org/W4312201104","https://openalex.org/W4316467893","https://openalex.org/W4321485320","https://openalex.org/W4379768401","https://openalex.org/W4388728297","https://openalex.org/W4389537586","https://openalex.org/W4389569142","https://openalex.org/W4391617972","https://openalex.org/W4394978477","https://openalex.org/W4396605932","https://openalex.org/W4397007852","https://openalex.org/W4403148339","https://openalex.org/W4403632506","https://openalex.org/W4407722128","https://openalex.org/W4408358594"],"related_works":["https://openalex.org/W4362595111","https://openalex.org/W3033316579","https://openalex.org/W4389569142","https://openalex.org/W3081749038","https://openalex.org/W3181045839","https://openalex.org/W2976334328","https://openalex.org/W2982701706","https://openalex.org/W2995877501","https://openalex.org/W2953406083","https://openalex.org/W4282968854"],"abstract_inverted_index":{"Osimertinib":[0],"is":[1],"the":[2,16,37,47,83,105,124,157,166,181],"mainstay":[3],"of":[4,39,72,85,102,107,126,150,184],"therapy":[5],"for":[6,180],"patients":[7],"with":[8,65,144,156,188],"non-small":[9],"cell":[10,34],"lung":[11],"cancer":[12],"(NSCLC)":[13],"driven":[14],"by":[15,81],"receptor":[17],"tyrosine":[18],"kinase":[19],"(RTK)":[20],"EGFR.":[21],"In":[22,68,136],"most":[23],"patients,":[24],"however,":[25],"therapeutic":[26],"pressure":[27],"promotes":[28],"RTK-dependent":[29,86],"mechanisms":[30],"that":[31,45],"support":[32],"tumor":[33,169],"survival":[35],"and":[36,60,98,116,130,152,195],"emergence":[38],"osimertinib":[40,55,79,128,146,151,189],"resistance.":[41,67],"Here,":[42],"we":[43],"found":[44],"inhibiting":[46],"proximal":[48],"RTK":[49],"signaling":[50],"intermediate":[51],"SOS1":[52,76,90,103,120,154,186],"promoted":[53],"continued":[54],"efficacy":[56],"in":[57,63,114,118,198],"sensitive":[58],"cells":[59,64,95,109,133],"restored":[61],"sensitivity":[62],"acquired":[66,127],"three-dimensional":[69],"spheroid":[70,112],"cultures":[71],"na\u00efve":[73],"NSCLC":[74],"cells,":[75],"inhibition":[77,91,101,121],"enhanced":[78],"potency":[80],"limiting":[82],"reactivation":[84],"adaptive":[87],"Ras":[88],"effectors.":[89],"resensitized":[92,131],"drug-tolerant":[93],"persister":[94],"to":[96,110,134,190],"osimertinib,":[97],"knockout":[99],"or":[100,147],"reduced":[104],"frequency":[106],"tumor-initiating":[108],"curb":[111],"growth":[113],"situ":[115],"tumorigenesis":[117],"vivo.":[119],"further":[122],"limited":[123],"development":[125],"resistance":[129,197],"resistant":[132],"osimertinib.":[135],"mice,":[137],"tumors":[138],"regressed":[139],"nearly":[140],"completely":[141],"when":[142],"treated":[143],"either":[145],"a":[148,153,160,177],"combination":[149,158,167],"inhibitor,":[155],"providing":[159],"slightly":[161],"greater":[162],"effect.":[163],"However,":[164],"only":[165],"delayed":[168],"regrowth":[170],"after":[171],"treatment":[172],"removal.":[173],"Our":[174],"data":[175],"provide":[176],"mechanistic":[178],"rationale":[179],"clinical":[182],"investigation":[183],"combining":[185],"inhibitors":[187],"achieve":[191],"more":[192],"durable":[193],"responses":[194],"suppress":[196],"NSCLC.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4416655751","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-11-25T00:00:00"}
